Should We Personalize Our Approach to Treating Hypertension? - Frankly Speaking Ep 341

<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341</a></p> <p>Overview: Listen in as we review a recent JAMA publication of a randomized controlled trial that quantified the benefits of a targeted approach to prescribing antihypertensive medications. Don’t miss this opportunity to keep your management of patients with hypertension up to date.</p> <p>Episode resource links:</p> <ul><li>Sundström J, Lind L, Nawrouzi S, et al. Heterogeneity in blood pressure response to 4 antihypertensive drugs: a randomized clinical trial. JAMA. Published April 11, 2023. doi:10.1001/jama.2023.3322</li> </ul> <p>Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato</p>